- Home
- TARA vs ACRE Comparison
TARA vs ACRE Comparison
Compare TARA & ACRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TARA | ACRE |
|---|---|---|
| Founded | N/A | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 292.9M | 254.1M |
| IPO Year | 2014 | 2011 |
Fundamental Metrics
Financial Performance| Metric | TARA | ACRE |
|---|---|---|
| Price | $4.78 | $4.88 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 4 |
| Target Price | ★ $24.40 | $5.38 |
| AVG Volume (30 Days) | ★ 727.9K | 385.6K |
| Earning Date | 05-01-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 11.58% |
| EPS Growth | ★ 38.25 | 26.17 |
| EPS | N/A | ★ 1.35 |
| Revenue | $2,948,000.00 | ★ $54,833,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $16.28 |
| P/E Ratio | ★ N/A | $3.56 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.77 | $4.05 |
| 52 Week High | $7.82 | $5.89 |
Technical Indicators
Market Signals| Indicator | TARA | ACRE |
|---|---|---|
| Relative Strength Index (RSI) | 42.13 | 46.66 |
| Support Level | $3.01 | $4.85 |
| Resistance Level | $5.53 | $5.36 |
| Average True Range (ATR) | 0.34 | 0.16 |
| MACD | -0.04 | -0.01 |
| Stochastic Oscillator | 30.29 | 43.17 |
Price Performance
Historical ComparisonAbout TARA Protara Therapeutics Inc.
Protara Therapeutics Inc is a clinical-stage biopharmaceutical company focused on advancing its therapies for the treatment of cancer and rare diseases. Its drug development pipeline includes: TARA-002, an investigational cell therapy in development for the treatment of non-muscle invasive bladder cancer (NMIBC) and lymphatic malformations (LMs); and IV Choline Chloride, an investigational phospholipid substrate replacement therapy, for patients receiving parenteral support, or PS, which includes both nutrition and fluids.
About ACRE Ares Commercial Real Estate Corporation
Ares Commercial Real Estate Corp is a specialty finance company and a Real Estate Investment Trust providing commercial real estate loans and related investments. It operates in one segment namely originating and managing a diversified portfolio of CRE debt-related investments. The group recognizes its revenues through the interest income it receives from loans.